Reporting and Adhoc Support


KMK reports monitor and track performance to drive insights quickly and effectively to help you better manage business.

KMK provides on-going reporting support for client (HQ and field users) to monitor and track the performance and drive insights quickly and effectively. We leverage cutting-edge visualization tools to deliver actionable suggestions to the users. KMK also delivers the customized reports and dashboards you need to stimulate business growth.

Some of the reports KMK offers include:

  • Incentive Compensation (IC) Scorecard Reports
  • National Sales Performance Tracker
  • Underlying Analytics for Multi-Channel promotion
  • Site Alert for Grower/Decliner
  • Patient Journey Summary
  • Payer Coverage and Market Access
  • Ad-hoc Reports Based on Integration of Pharmaceutical Data Source

Related insights

KMK Donates to COVID Relief Effort in India


Making Remote Work in India with Pratik Panchal

KMK Consulting, Inc. Earns 2021 Great Place to Work Certification™

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

KMK Welcomes Oncology Market Research Veteran Lisa Logan

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

KMK Value Based Medicine

Unlock forward looking Insights via Machine Learning

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

KMK’s Split Credit Tool Improves IC Performance

KMK’s Employee Performance Tool Streamlines HQ/Sales Rep Calibration

Field Force Re-Optimization in Anticipation of Loss of Exclusivity (LOE)

IC Plan Design in Defense of Competitive Entry

Sales Force Effectiveness for Top 20 Pharma